至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Self-encapsulation and controlled release of recombinant proteins using novel silica-forming peptides as fusion linkers.

Int. J. Biol. Macromol.. 2019; 
AbdelhamidMohamed A A,YeoKi Baek,KiMi-Ran,PackSeung
Products/Services Used Details Operation
Peptide Synthesis … 2. Materials and methods. 2.1. Materials. The Volp1 and Salp1 peptides (10 mg) were synthesized by Genscript (Piscataway, NJ, USA). Tetramethyl orthosilicate (TMOS) was used as a silica precursor and was purchased from Sigma Aldrich (St. Louis, MO, USA) … Get A Quote

摘要

Recently, the potential use of biomimetic silica as smart matrices for the auto-encapsulation and controlled release of functional proteins has gained increased interest because of the mild synthesis conditions. Inspired by biological silicification, in this study, we studied novel silica-forming peptides (SFPs), Volp1 and Salp1, to mediate the generation of silica hybrids in vitro. The fusion of SFPs to model fluorescent proteins directed their auto-encapsulation in wet sol-gel silica materials. Furthermore, the SFPs served as affinity linkers for the immobilization of recombinant proteins in silica. Interestingly, the SFP fusion proteins modulated silicic acid polycondensation and allowed for th... More

关键词

Protein immobilization,Silica-forming peptide,Sustained rel